www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

   

China to start 2nd trial for bird flu vaccine

(Reuters)
Updated: 2006-10-12 16:36

A Chinese company that is developing a H5N1 bird flu vaccine for humans plans to kick off a second clinical trial before the end of the year and will have its production capacity expanded ten-fold by mid-2007.

"The second clinical trial should be over by July or August next year, just before the flu season begins," Yin Weidong, managing director of state-backed Beijing Sinovac Biotech Co., told Reuters in an interview on Thursday.

He tried to ease concerns over using a strain of the virus found in Vietnam in the vaccine, saying it would offer some protection against other H5N1 strains.

The company needs to obtain the approval of the State Food and Drug Administration (SFDA) for the second trial and will file its application with the agency within the next two weeks.

"The government values this project very highly and it will get going faster," Yin said. He added that the World Health Organisation had provided advice in the first clinical trial and would probably do so again in the second trial.

Sinovac ran its first clinical trial involving 120 volunteers in Beijing this year.
It published its findings in The Lancet medical journal in September, saying the experimental vaccine was effective and well tolerated at low doses.

It used whole-virus vaccine in 1.25, 2.5, 5 and 10 microgram amounts, but the 10 microgram dose was found to be most effective in producing an immune response.

The volunteers, aged between 18 and 60, did not suffer serious side effects, but some experienced pain, swelling and fever.

The second trial will have a wider age limit, taking in people below 18 and over 60, but Yin said the drug administration would make the final decision.

Apart from Beijing, Sinovac will look for volunteers in two other cities, most likely in southern China. There will be two dosages: 5 and 10 micrograms.

By mid-2007, Sinovac will have expanded its production capacity to 20 million doses from a current 2 million, but when the vaccine goes into production will hinge on how soon it secures orders.

Sinovac and several companies around the world are in a race to develop a vaccine to combat what experts fear would be a flu pandemic triggered by the H5N1 bird flu virus, which has killed 148 people since late 2003.

Although it remains a disease among birds, scientists say it could wreak havoc and kill millions if it mutates and learns to transmit efficiently among humans.

Some experts, however, question the rationale behind designing these "pre-pandemic vaccines" based on a H5N1 strain found in Vietnam in recent years, saying they might not protect against other H5N1 strains and the eventual pandemic strain.

At least two other H5N1 strains have become geographically more widespread; with one spreading across not only Asia, but parts of Europe, Africa and the Middle East.
But Yin said there should be some amount of cross protection.

"Even though the virus is changing, it is still H5N1. We are facing one enemy," he said.

 
 

主站蜘蛛池模板: 日韩欧美中文字幕一区二区三区 | 国产精品亚洲一区二区在线观看 | 91精品国产91热久久久久福利 | 成人在线视频一区 | 国产一区二区三区久久 | 一级做a级爰片性色毛片视频 | 玖草在线资源 | 成人精品免费网站 | 亚洲一片 | 99爱免费观看视频在线 | 成人网18免费视频 | 欧美一级欧美一级高清 | 草草影院永久在线观看 | 日韩成人一级 | 国产美女精品视频 | 看一级毛片 | 日韩加勒比在线 | 亚洲综合国产一区在线 | 国产一级内谢a级高清毛片 国产一级片毛片 | 国产免费爱在线观看视频 | 亚洲国产精品ⅴa在线观看 亚洲国产精品aaa一区 | 久久久国产99久久国产首页 | 久久精品一区 | 特级毛片8级毛片免费观看 特级毛片免费观看视频 | 中日韩一区二区三区 | 久久91精品国产91久久户 | 国产做国产爱免费视频 | 亚洲国产精品自在现线让你爽 | 国产成人mv在线观看入口视频 | 日本乱人伦片中文字幕三区 | 自拍在线视频 | 欧美成人性生活视频 | 91免费国产高清观看 | 亚洲午夜精品一级在线播放放 | 国产一区二区精品久久凹凸 | 久久tv免费国产高清 | 在线视频一二三区 | 另类欧美日韩 | 不卡午夜| 三级视频中文字幕 | 精品免费国产一区二区三区 |